Company / Operating Income
Avantor Operating Income History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$246.2M
FY2025
5-year range
-$246.2M / $1.1B
FY2021-FY2025
Trend
-122.7%
vs FY2024
Sector context
#142 of 156
Health Care
What the data says
Among 156 Health Care companies, Avantor is in the bottom 9% for operating income. Operating Income has fluctuated over the past 9 years, ranging from -$246M in FY2025 to $1.1B in FY2024.
Based on SEC 10-K filings.
-$246M in FY2025.
Declined from $696M to -$246M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 156This company -$246.2M Sector average $733.1M
▼
-133.6% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 122.7% year-over-year.
- Ranks #142 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$246.2M | -122.7% |
| FY2024 | $1.1B | +55.8% |
| FY2023 | $696.4M | -1.5% |
| FY2022 | $706.8M | -27.3% |
| FY2021 | $972.2M | +37.5% |
| FY2020 | $706.8M | +435.9% |
| FY2019 | -$210.4M | -150.9% |
| FY2018 | $413.5M | +296.5% |
| FY2017 | -$210.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026